Your browser doesn't support javascript.
loading
Francisella tularensis Bone and Joint Infections: United States, 2004-2023.
Beeson, Amy M; Baker, Molly; Dell, BreeAnna; Schnitzler, Hannah; Oltean, Hanna N; Woodall, Tracy; Riedo, Francis; Schwartz, Amy; Petersen, Jeannine; Hinckley, Alison F; Marx, Grace E.
Afiliación
  • Beeson AM; Centers for Disease Control and Prevention, Division of Vector-Borne Diseases, Fort Collins, Colorado, USA.
  • Baker M; Missouri Department of Health and Senior Services, Jefferson City, Missouri, USA.
  • Dell B; Public Health-Seattle and King County, Seattle, Washington, USA.
  • Schnitzler H; Washington State Department of Health, Shoreline, Washington, USA.
  • Oltean HN; Washington State Department of Health, Shoreline, Washington, USA.
  • Woodall T; Colorado Department of Public Health and Environment, Denver, Colorado, USA.
  • Riedo F; EvergreenHealth, Kirkland, Washington, USA.
  • Schwartz A; Centers for Disease Control and Prevention, Division of Vector-Borne Diseases, Fort Collins, Colorado, USA.
  • Petersen J; Centers for Disease Control and Prevention, Division of Vector-Borne Diseases, Fort Collins, Colorado, USA.
  • Hinckley AF; Centers for Disease Control and Prevention, Division of Vector-Borne Diseases, Fort Collins, Colorado, USA.
  • Marx GE; Centers for Disease Control and Prevention, Division of Vector-Borne Diseases, Fort Collins, Colorado, USA.
Clin Infect Dis ; 78(Suppl 1): S67-S70, 2024 01 31.
Article en En | MEDLINE | ID: mdl-38294110
ABSTRACT
Tularemia is caused by the highly infectious bacterium Francisella tularensis, which is recognized as a Tier 1 bioterrorism agent. Tularemia has a range of recognized clinical manifestations, but fewer than 20 bone or joint infections from 6 countries have been reported in the literature to date. This series includes 13 cases of F. tularensis septic arthritis or osteomyelitis in the United States during 2004-2023 and describes exposures, clinical presentation, diagnosis, and outcomes for this rare but severe form of tularemia. Clinicians should consider F. tularensis in patients with compatible exposures or a history of joint replacement or immunosuppression.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tularemia / Artritis Infecciosa / Francisella tularensis Tipo de estudio: Diagnostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tularemia / Artritis Infecciosa / Francisella tularensis Tipo de estudio: Diagnostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Año: 2024 Tipo del documento: Article